ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Business Segments Zhejiang Jolly Pharmaceutical Co.,LTD
Equities
300181
CNE100001096
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.72 CNY | -0.51% |
|
-4.17% | +9.94% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Manufacturing | 778M | 980M | 1.32B | 1.64B | 1.73B | |||||
Gross Profit | - | - | - | - | - | |||||
Pharmaceutical Distribution | 129M | 105M | 131M | 147M | 209M | |||||
Gross Profit | - | - | - | - | - | |||||
Unallocated Other Operations | 4.15M | 5.32M | 7.26M | 18.23M | 5.2M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 911M | 1.09B | 1.46B | 1.81B | 1.94B | |||||
Total Assets | 2.05B | 2.47B | 2.75B | 3.64B | 3.63B | |||||
Interest Expense | -22.81M | -17.93M | -12.07M | -8.32M | -7.62M | |||||
Income Tax Expense | 5.27M | 13.87M | 30.33M | 38.6M | 55.88M | |||||
D&A | 47.87M | 53.3M | 56.53M | 59.78M | 64.03M | |||||
CAPEX | -40.46M | -58.35M | -148M | -178M | -132M | |||||
Net Income | 25.59M | 88.8M | 179M | 273M | 383M | |||||
EBT | 29.16M | 109M | 222M | 324M | 447M | |||||
Operating Income | 29.3M | 110M | 225M | 337M | 449M |